Molecular Mechanisms of Anti-metastatic Activity of Curcumin.
Identifieur interne : 003D84 ( Ncbi/Curation ); précédent : 003D83; suivant : 003D85Molecular Mechanisms of Anti-metastatic Activity of Curcumin.
Auteurs : Y I Deng [Australie] ; Elise Verron [France] ; Ramin Rohanizadeh [Australie]Source :
- Anticancer research [ 1791-7530 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Antinéoplasiques, Curcumine.
- Humains, Invasion tumorale, Métastase tumorale.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Antineoplastic Agents, Curcumin.
- prevention & control : Neoplasm Invasiveness, Neoplasm Metastasis.
- Humans.
Abstract
Cancer is the leading cause of death worldwide. Although cancer occurs as a localized disease, its morbidity and mortality rates remain high due to the ability of cancer cells to break-off from the primary tumor and spread to distant organs. Currently, chemotherapy is the main treatment for cancer; however, the increase in proportion of drug-resistant cancer cells and unpleasant side-effects of chemotherapy are still the major challenges in cancer therapy. Curcumin is a natural polyphenol compound and the main bioactive constituent of Indian spice turmeric, widely used in Indian and Chinese medicines. Curcumin has well-known therapeutic actions, including anti-inflammatory, anti-microbial, anti-oxidant and anti-cancer properties. Curcumin induces cancer cell apoptosis through regulating various signaling pathways and arresting tumor cell cycle. Curcumin's therapeutic/ preventative actions on metastatic cancers have not been yet fully understood and studied. The present review explores the potential anti-metastatic mechanisms of curcumin, including inhibition of transcription factors and their signaling pathways (e.g., NF-κB, ApP-1 and STAT3), inflammatory cytokines (e.g., CXCL1, CXCL2, IL-6, IL-8), multiple proteases (e.g., uPA, MMPs), multiple protein kinases (e.g., MAPKs, FAK), regulation of miRNAs (e.g., miR21, miR181b) and heat shock proteins (HLJ1). In addition, possible synergistic actions of combination therapy of curcumin with current chemotherapies are discussed in this review.
DOI: 10.21873/anticanres.11147
PubMed: 27793885
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001666
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001644
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001644
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :003D84
Links to Exploration step
pubmed:27793885Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Molecular Mechanisms of Anti-metastatic Activity of Curcumin.</title><author><name sortKey="Deng, Y I" sort="Deng, Y I" uniqKey="Deng Y" first="Y I" last="Deng">Y I Deng</name><affiliation wicri:level="4"><nlm:affiliation>University of Sydney, Faculty of Pharmacy, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Sydney, Faculty of Pharmacy, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Verron, Elise" sort="Verron, Elise" uniqKey="Verron E" first="Elise" last="Verron">Elise Verron</name><affiliation wicri:level="4"><nlm:affiliation>Université de Nantes, UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Nantes, UFR des Sciences Pharmaceutiques et Biologiques, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement><settlement type="city">Nantes</settlement></placeName><orgName type="university">Université de Nantes</orgName></affiliation></author><author><name sortKey="Rohanizadeh, Ramin" sort="Rohanizadeh, Ramin" uniqKey="Rohanizadeh R" first="Ramin" last="Rohanizadeh">Ramin Rohanizadeh</name><affiliation wicri:level="4"><nlm:affiliation>University of Sydney, Faculty of Pharmacy, Sydney, Australia ramin.rohanizadeh@sydney.edu.au.</nlm:affiliation><country wicri:rule="url">Australie</country><wicri:regionArea>University of Sydney, Faculty of Pharmacy, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27793885</idno><idno type="pmid">27793885</idno><idno type="doi">10.21873/anticanres.11147</idno><idno type="wicri:Area/PubMed/Corpus">001666</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001666</idno><idno type="wicri:Area/PubMed/Curation">001644</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001644</idno><idno type="wicri:Area/PubMed/Checkpoint">001644</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001644</idno><idno type="wicri:Area/Ncbi/Merge">003D84</idno><idno type="wicri:Area/Ncbi/Curation">003D84</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Molecular Mechanisms of Anti-metastatic Activity of Curcumin.</title><author><name sortKey="Deng, Y I" sort="Deng, Y I" uniqKey="Deng Y" first="Y I" last="Deng">Y I Deng</name><affiliation wicri:level="4"><nlm:affiliation>University of Sydney, Faculty of Pharmacy, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>University of Sydney, Faculty of Pharmacy, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author><author><name sortKey="Verron, Elise" sort="Verron, Elise" uniqKey="Verron E" first="Elise" last="Verron">Elise Verron</name><affiliation wicri:level="4"><nlm:affiliation>Université de Nantes, UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Nantes, UFR des Sciences Pharmaceutiques et Biologiques, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement><settlement type="city">Nantes</settlement></placeName><orgName type="university">Université de Nantes</orgName></affiliation></author><author><name sortKey="Rohanizadeh, Ramin" sort="Rohanizadeh, Ramin" uniqKey="Rohanizadeh R" first="Ramin" last="Rohanizadeh">Ramin Rohanizadeh</name><affiliation wicri:level="4"><nlm:affiliation>University of Sydney, Faculty of Pharmacy, Sydney, Australia ramin.rohanizadeh@sydney.edu.au.</nlm:affiliation><country wicri:rule="url">Australie</country><wicri:regionArea>University of Sydney, Faculty of Pharmacy, Sydney</wicri:regionArea><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region><settlement type="city">Sydney</settlement></placeName><orgName type="university">Université de Sydney</orgName></affiliation></author></analytic><series><title level="j">Anticancer research</title><idno type="eISSN">1791-7530</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (pharmacology)</term><term>Curcumin (pharmacology)</term><term>Humans</term><term>Neoplasm Invasiveness (prevention & control)</term><term>Neoplasm Metastasis (prevention & control)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antinéoplasiques (pharmacologie)</term><term>Curcumine (pharmacologie)</term><term>Humains</term><term>Invasion tumorale ()</term><term>Métastase tumorale ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antineoplastic Agents</term><term>Curcumin</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antinéoplasiques</term><term>Curcumine</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Neoplasm Invasiveness</term><term>Neoplasm Metastasis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Invasion tumorale</term><term>Métastase tumorale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Cancer is the leading cause of death worldwide. Although cancer occurs as a localized disease, its morbidity and mortality rates remain high due to the ability of cancer cells to break-off from the primary tumor and spread to distant organs. Currently, chemotherapy is the main treatment for cancer; however, the increase in proportion of drug-resistant cancer cells and unpleasant side-effects of chemotherapy are still the major challenges in cancer therapy. Curcumin is a natural polyphenol compound and the main bioactive constituent of Indian spice turmeric, widely used in Indian and Chinese medicines. Curcumin has well-known therapeutic actions, including anti-inflammatory, anti-microbial, anti-oxidant and anti-cancer properties. Curcumin induces cancer cell apoptosis through regulating various signaling pathways and arresting tumor cell cycle. Curcumin's therapeutic/ preventative actions on metastatic cancers have not been yet fully understood and studied. The present review explores the potential anti-metastatic mechanisms of curcumin, including inhibition of transcription factors and their signaling pathways (e.g., NF-κB, ApP-1 and STAT3), inflammatory cytokines (e.g., CXCL1, CXCL2, IL-6, IL-8), multiple proteases (e.g., uPA, MMPs), multiple protein kinases (e.g., MAPKs, FAK), regulation of miRNAs (e.g., miR21, miR181b) and heat shock proteins (HLJ1). In addition, possible synergistic actions of combination therapy of curcumin with current chemotherapies are discussed in this review.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D84 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 003D84 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:27793885
|texte= Molecular Mechanisms of Anti-metastatic Activity of Curcumin.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:27793885" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |